COMMUNIQUÉS West-GlobeNewswire
-
Virbac : Declaration of the number of shares and voting rights as of July 2017, 31.
11/09/2017 - 09:20 -
Principal Investigator Dr. James Gulley to Provide Presentation Entitled "Therapeutic Vaccines in Prostate Cancer" at the ESMO 2017 Congress
11/09/2017 - 09:15 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
11/09/2017 - 09:00 -
Solon Eiendom ASA : Primary insider notification
11/09/2017 - 08:30 -
Xbrane confirms order of Spherotide to value of SEK 8.5 million and more than 10,000 doses sold
11/09/2017 - 08:00 -
Infant Bacterial Therapeutics announces that top line data demonstrate similar safety and tolerability profile in the active and placebo groups.
11/09/2017 - 08:00 -
SelectMDx Outperforms PCA3 Stratifying Men for mpMRI
11/09/2017 - 07:00 -
SelectMDx plus performant que PCA3 pour sélectionner les hommes devant passer une IRM-mp
11/09/2017 - 07:00 -
INNATE PHARMA : New preclinical data further strengthen the rationale of IPH5401 and monalizumab
11/09/2017 - 07:00 -
INNATE PHARMA: nouvelles données précliniques renforçant le rationnel d'IPH5401 et monalizumab
11/09/2017 - 07:00 -
First Patients Enrolled in UK's Early Access to Medicines Scheme for Santhera's Raxone® in Duchenne Muscular Dystrophy (DMD)
11/09/2017 - 07:00 -
Targovax ASA: Three posters presented at ESMO conference
11/09/2017 - 07:00 -
Sanofi, Regeneron: Dupilumab Hits Main Objectives in Late-Stage Asthma Trial
11/09/2017 - 06:58 -
Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude de phase 3 consacrée au dupilumab dans le traitement de l'asthme persistant non contrôlé
11/09/2017 - 06:58 -
Novartis Phase III study demonstrates adjuvant Tafinlar® + Mekinist® reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma
11/09/2017 - 00:05 -
Novartis presents new data at EURETINA 2017 confirming Lucentis® efficacy and durability vs aflibercept
09/09/2017 - 11:00 -
L'Association internationale pour l'étude du cancer du poumon annonce des sélections de rapports pour la 18e Conférence mondiale sur le cancer du poumon
08/09/2017 - 23:41 -
LifeVantage Corporation élargit sa présence mondiale avec une expansion en Allemagne
08/09/2017 - 18:18 -
PCI Biotech: Capital increase registered and listing of new shares
08/09/2017 - 14:34
Pages